Toxicology Study of Repeat Intracerebral Administration of a Measles Virus Derivative Producing Carcinoembryonic Antigen in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas
Rae Myers(Mayo Clinic in Arizona), Evanthia Galanis(Mayo Clinic in Arizona), Mark J. Federspiel(Mayo Clinic in Arizona), Timothy J. Kaufmann(Mayo Clinic), James Krempski(University of North Carolina at Chapel Hill), Mary Harvey(Mayo Clinic in Arizona), Michael Blanco(Mayo Clinic), Steven E. Shelton(UW Health University Hospital), Paula J. Zollman(Mayo Clinic), Diane Soeffker(Mayo Clinic), Corey Raffel(University of California, San Francisco), Suzanne Greiner(Mayo Clinic in Arizona)
Cited by 87
Related Papers
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k
Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
|Journal of Clinical Oncology|2005|695
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
|Neuro-Oncology|2015|670
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases
|Neuro-Oncology|2020|258
Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer
|The Journal of Immunology|2011|250